• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2001年至2021年肺泡蛋白沉积症的文献计量分析

A Bibliometric Analysis of Pulmonary Alveolar Proteinosis From 2001 to 2021.

作者信息

Liu Shixu, Cui Xiangning, Xia Kun, Wang Dandan, Han Jing, Yao Xiaoyan, Liu Xiaohong, Bian Lingjie, Zhang Jinzhi, Li Guangxi

机构信息

Guanganmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.

Graduate School of China Academy of Chinese Medical Sciences, Beijing, China.

出版信息

Front Med (Lausanne). 2022 Mar 22;9:846480. doi: 10.3389/fmed.2022.846480. eCollection 2022.

DOI:10.3389/fmed.2022.846480
PMID:35391885
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8980592/
Abstract

BACKGROUND

Pulmonary alveolar proteinosis (PAP) is a rare syndrome first described by Rosen et al. in 1958. Despite our considerably evolved understanding of PAP over the past decades, no bibliometric studies have been reported on this field. We aimed to analyze and visualize the research hotspots and current trends of the PAP research field using a bibliometric analysis to help understand the future development of basic and clinical research.

METHODS

The literature regarding PAP was culled from the Web of Science Core Collection (WoSCC) database. Data were extracted from the relevant articles and visually analyzed using CiteSpace and VOSviewer software.

RESULTS

Nine hundred and nine qualifying articles were included in the analysis. Publications regarding PAP increased over time. These articles mainly come from 407 institutions of 57 countries. The leading countries were the USA and Japan. University of Cincinnati (USA) and Niigata University (Japan) featured the highest number of publications among all institutions. Bruce C Trapnell exerts a significant publication impact and has made the most outstanding contributions in the field of PAP. was the journal with the most publications, and was the most commonly cited journal. All the top 5 co-cited journals belong to Q1. Keyword citation bursts revealed that inflammation, deficiency, tissue resident macrophage, classification, autoimmune pulmonary alveolar proteinosis, sarcoidosis, gm csf, high resolution ct, and fetal monocyte were the emerging research hotspots.

CONCLUSION

Research on PAP is prosperous. International cooperation is also expected to deepen and strengthen in the future. Our results indicated that the etiology and pathogenesis of PAP, current and emerging therapies, especially the novel pathogenesis-based options will remain research hotspots in the future.

摘要

背景

肺泡蛋白沉积症(PAP)是一种罕见综合征,于1958年由罗森等人首次描述。尽管在过去几十年里我们对PAP的认识有了很大进展,但尚未有关于该领域的文献计量学研究报道。我们旨在通过文献计量学分析来分析和可视化PAP研究领域的热点和当前趋势,以帮助理解基础和临床研究的未来发展。

方法

从科学网核心合集(WoSCC)数据库中筛选有关PAP的文献。从相关文章中提取数据,并使用CiteSpace和VOSviewer软件进行可视化分析。

结果

909篇符合条件的文章纳入分析。关于PAP的出版物数量随时间增加。这些文章主要来自57个国家的407个机构。领先国家是美国和日本。美国辛辛那提大学和日本新潟大学在所有机构中发表的文章数量最多。布鲁斯·C·特拉普内尔产生了重大的出版影响力,在PAP领域做出了最杰出的贡献。 是发表文章最多的期刊, 是被引用最多的期刊。所有前5名的共被引期刊都属于Q1区。关键词共现分析显示,炎症、缺陷、组织驻留巨噬细胞、分类、自身免疫性肺泡蛋白沉积症、结节病、粒细胞巨噬细胞集落刺激因子、高分辨率CT和胎儿单核细胞是新兴的研究热点。

结论

PAP的研究很繁荣。预计未来国际合作也将深化和加强。我们的结果表明,PAP的病因和发病机制、当前和新兴的治疗方法,尤其是基于新发病机制选择的治疗方法,将仍然是未来的研究热点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5de5/8980592/ac601cca831f/fmed-09-846480-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5de5/8980592/15b01d0b534b/fmed-09-846480-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5de5/8980592/51067da66665/fmed-09-846480-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5de5/8980592/45c2a4abc7a7/fmed-09-846480-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5de5/8980592/956b0c7caf09/fmed-09-846480-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5de5/8980592/c5a839d17d11/fmed-09-846480-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5de5/8980592/d3f9c5284b74/fmed-09-846480-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5de5/8980592/ac601cca831f/fmed-09-846480-g0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5de5/8980592/15b01d0b534b/fmed-09-846480-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5de5/8980592/51067da66665/fmed-09-846480-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5de5/8980592/45c2a4abc7a7/fmed-09-846480-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5de5/8980592/956b0c7caf09/fmed-09-846480-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5de5/8980592/c5a839d17d11/fmed-09-846480-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5de5/8980592/d3f9c5284b74/fmed-09-846480-g0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5de5/8980592/ac601cca831f/fmed-09-846480-g0007.jpg

相似文献

1
A Bibliometric Analysis of Pulmonary Alveolar Proteinosis From 2001 to 2021.2001年至2021年肺泡蛋白沉积症的文献计量分析
Front Med (Lausanne). 2022 Mar 22;9:846480. doi: 10.3389/fmed.2022.846480. eCollection 2022.
2
Bibliometric Analysis of Birt-Hogg-Dubé Syndrome From 2001 to 2021.2001年至2021年Birt-Hogg-Dubé综合征的文献计量分析
Front Med (Lausanne). 2022 Apr 11;9:857127. doi: 10.3389/fmed.2022.857127. eCollection 2022.
3
A bibliometric analysis of the research hotspots and frontiers related to cell death in spinal cord injury.脊髓损伤中细胞死亡相关研究热点与前沿的文献计量分析
Front Neurol. 2024 Jan 5;14:1280908. doi: 10.3389/fneur.2023.1280908. eCollection 2023.
4
Pulmonary alveolar proteinosis: time to shift?肺泡蛋白沉积症:是时候做出改变了吗?
Expert Rev Respir Med. 2015 Jun;9(3):337-49. doi: 10.1586/17476348.2015.1035259. Epub 2015 Apr 12.
5
Autoantibodies against granulocyte macrophage colony-stimulating factor are diagnostic for pulmonary alveolar proteinosis.抗粒细胞巨噬细胞集落刺激因子自身抗体对肺泡蛋白沉积症具有诊断意义。
Am J Respir Cell Mol Biol. 2002 Oct;27(4):481-6. doi: 10.1165/rcmb.2002-0023OC.
6
Research Trends on Pulmonary Rehabilitation: A Bibliometric Analysis From 2011 to 2020.肺康复的研究趋势:2011年至2020年的文献计量分析
Front Med (Lausanne). 2022 Jun 6;9:887793. doi: 10.3389/fmed.2022.887793. eCollection 2022.
7
Pulmonary alveolar proteinosis: a bench-to-bedside story of granulocyte-macrophage colony-stimulating factor dysfunction.肺泡蛋白沉积症:粒细胞-巨噬细胞集落刺激因子功能障碍的从 bench 到床边的故事 。 (注:这里“bench-to-bedside”直译为“从实验台到床边”,意译为“从基础研究到临床应用” ,更符合语境,即阐述了肺泡蛋白沉积症与粒细胞 - 巨噬细胞集落刺激因子功能障碍在基础研究到临床方面的关联故事 )
Chest. 2009 Aug;136(2):571-577. doi: 10.1378/chest.08-2943.
8
Mapping current trends and hotspots in myasthenia gravis from 2003 to 2022: a bibliometric analysis.2003年至2022年重症肌无力的当前趋势和热点图谱:一项文献计量分析
Front Neurol. 2023 Dec 28;14:1320344. doi: 10.3389/fneur.2023.1320344. eCollection 2023.
9
The molecular basis of pulmonary alveolar proteinosis.肺气泡蛋白质沉积症的分子基础。
Clin Immunol. 2010 May;135(2):223-35. doi: 10.1016/j.clim.2010.02.017. Epub 2010 Mar 25.
10
Bibliometric analysis of global research trends on male osteoporosis: a neglected field deserves more attention.男性骨质疏松症全球研究趋势的文献计量分析:一个被忽视的领域值得更多关注。
Arch Osteoporos. 2021 Oct 11;16(1):154. doi: 10.1007/s11657-021-01016-2.

引用本文的文献

1
Bibliometric and Visualization Analysis of Research Hotspots and Frontiers in Endoscopic Lumbar Discectomy.内镜下腰椎间盘切除术研究热点与前沿的文献计量学及可视化分析
J Pain Res. 2024 Jun 18;17:2165-2190. doi: 10.2147/JPR.S450586. eCollection 2024.
2
Global trends and hotspots in research of robotic surgery in oncology: A bibliometric and visual analysis from 2002 to 2021.肿瘤学机器人手术研究的全球趋势与热点:2002年至2021年的文献计量与可视化分析
Front Oncol. 2022 Nov 11;12:1055118. doi: 10.3389/fonc.2022.1055118. eCollection 2022.
3
Bibliometric and visual analysis of intestinal ischemia reperfusion from 2004 to 2022.

本文引用的文献

1
A Bibliometric Analysis of Pyroptosis From 2001 to 2021.2001 年至 2021 年细胞焦亡的文献计量学分析
Front Immunol. 2021 Aug 18;12:731933. doi: 10.3389/fimmu.2021.731933. eCollection 2021.
2
Update on Diagnosis and Treatment of Adult Pulmonary Alveolar Proteinosis.成人肺泡蛋白沉积症的诊断与治疗进展
Ther Clin Risk Manag. 2021 Aug 10;17:701-710. doi: 10.2147/TCRM.S193884. eCollection 2021.
3
Inhaled Molgramostim Therapy in Autoimmune Pulmonary Alveolar Proteinosis.吸入莫拉司亭治疗自身免疫性肺性肺泡蛋白沉积症。
2004年至2022年肠道缺血再灌注的文献计量学与可视化分析
Front Med (Lausanne). 2022 Aug 15;9:963104. doi: 10.3389/fmed.2022.963104. eCollection 2022.
N Engl J Med. 2020 Oct 22;383(17):1635-1644. doi: 10.1056/NEJMoa1913590. Epub 2020 Sep 7.
4
Inhaled GM-CSF for Pulmonary Alveolar Proteinosis.吸入 GM-CSF 治疗肺泡蛋白沉积症。
N Engl J Med. 2019 Sep 5;381(10):923-932. doi: 10.1056/NEJMoa1816216.
5
Pulmonary alveolar proteinosis.肺泡蛋白沉积症。
Nat Rev Dis Primers. 2019 Mar 7;5(1):16. doi: 10.1038/s41572-019-0066-3.
6
Statin as a novel pharmacotherapy of pulmonary alveolar proteinosis.他汀类药物作为一种新型的肺泡蛋白沉积症的药物治疗方法。
Nat Commun. 2018 Aug 7;9(1):3127. doi: 10.1038/s41467-018-05491-z.
7
Prevalence and healthcare burden of pulmonary alveolar proteinosis.肺泡蛋白沉积症的患病率和医疗负担。
Orphanet J Rare Dis. 2018 Jul 31;13(1):129. doi: 10.1186/s13023-018-0846-y.
8
Rituximab for auto-immune alveolar proteinosis, a real life cohort study.利妥昔单抗治疗自身免疫性肺泡蛋白沉积症的真实世界队列研究。
Respir Res. 2018 Apr 25;19(1):74. doi: 10.1186/s12931-018-0780-5.
9
Pulmonary alveolar proteinosis in adults: pathophysiology and clinical approach.成人肺泡蛋白沉积症:病理生理学和临床方法。
Lancet Respir Med. 2018 Jul;6(7):554-565. doi: 10.1016/S2213-2600(18)30043-2. Epub 2018 Feb 1.
10
Targeting cholesterol homeostasis in lung diseases.靶向肺部疾病中的胆固醇动态平衡。
Sci Rep. 2017 Aug 31;7(1):10211. doi: 10.1038/s41598-017-10879-w.